NOVEL EGFR/PI3K DUAL-TARGETING NANOPARTICLES INDUCE IMMUNOGENIC CELL DEATH IN BLADDER CANCER

被引：0

作者：

Zhu, Zheng ^{[1
]}

Xue, Xiangdong ^{[2
]}

Zhou, Gang ^{[3
]}

Song, Zewen ^{[4
]}

Li, Guoyin ^{[5
]}

机构：

[1] Harvard Med Sch, West Roxbury, MA USA

[2] Shanghai Jiao Tong Univ, Shanghai, Peoples R China

[3] Fourth Millitary Med Univ, Xian, Peoples R China

[4] Cent South Univ, Changsha, Peoples R China

[5] Zhoukou Normal Univ, Zhoukou, Henan, Peoples R China

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷

关键词：

D O I：

10.1136/jitc-2022-SITC2022.1358

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1358

引用

页码：A1409 / A1409

页数：1

共 50 条

[21] Targeting the PI3K signaling pathway in cancer [J].

Wong, Kwok-Kin ;

Engelman, Jeffrey A. ;

Cantley, Lewis C. .

CURRENT OPINION IN GENETICS & DEVELOPMENT, 2010, 20 (01) :87-90

[22] Lysoglycosphingolipids have the ability to induce cell death through direct PI3K inhibition [J].

Watanabe, Ryosuke ;

Tsuji, Daisuke ;

Tanaka, Hiroki ;

Uno, Michael Shintaro ;

Ohnishi, Yukiya ;

Kitaguchi, Shindai ;

Matsugu, Tsuyoshi ;

Nakae, Ryuto ;

Teramoto, Hiromi ;

Yamamoto, Kei ;

Shinohara, Yasuo ;

Hirokawa, Takatsugu ;

Okino, Nozomu ;

Ito, Makoto ;

Itoh, Kohji .

JOURNAL OF NEUROCHEMISTRY, 2023, 167 (06) :753-765

[23] The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma [J].

Liangtao Ye ;

Julia Mayerle ;

Andreas Ziesch ;

Florian P. Reiter ;

Alexander L. Gerbes ;

Enrico N. De Toni .

Cell Death Discovery, 5

[24] The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma [J].

Ye, Liangtao ;

Mayerle, Julia ;

Ziesch, Andreas ;

Reiter, Florian P. ;

Gerbes, Alexander L. ;

De Toni, Enrico N. .

CELL DEATH DISCOVERY, 2019, 5 (1)

[25] The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer [J].

Shimizu, Toshio ;

Tolcher, Anthony W. ;

Papadopoulos, Kyriakos P. ;

Beeram, Muralidhar ;

Rasco, Drew W. ;

Smith, Lon S. ;

Gunn, Shelly ;

Smetzer, Leslie ;

Mays, Theresa A. ;

Kaiser, Brianne ;

Wick, Michael J. ;

Alvarez, Cathy ;

Cavazos, Aracely ;

Mangold, Gina L. ;

Patnaik, Amita .

CLINICAL CANCER RESEARCH, 2012, 18 (08) :2316-2325

[26] Targeting the PI3K/Akt Cell Survival Pathway to Induce Cell Death of HIV-1 Infected Macrophages with Alkylphospholipid Compounds [J].

Lucas, Amanda ;

Kim, Yuri ;

Rivera-Pabon, Omayra ;

Chae, Sunju ;

Kim, Dong-Hyun ;

Kim, Baek .

PLOS ONE, 2010, 5 (09) :1-8

[27] Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma [J].

Bang, Jieun ;

Jun, Mihyeon ;

Lee, Soyun ;

Moon, Hyuk ;

Ro, Simon Weonsang .

PHARMACEUTICS, 2023, 15 (08)

[28] Saikosaponin-A Exhibits Antipancreatic Cancer Activity by Targeting the EGFR/PI3K/Akt Pathway [J].

Shi, Chengda ;

Sun, Linglin ;

Fang, Rong ;

Zheng, Shuying ;

Yu, Mingming ;

Li, Qiang .

CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023, 24 (04) :579-588

[29] Dual targeting of PI3K and mTOR induce necroptosis to enhance therapeutic efficacy in pancreatic neuroendocrine tumors [J].

Pan, Jialing ;

Ye, Mujie ;

Bai, Jian'an ;

Xu, Ruitong ;

Yan, Lijun ;

Zhang, Jingtian ;

Wang, Hongbo ;

Wang, Honglin ;

Tian, Ye ;

Zhang, HongRu ;

Tang, Qiyun .

Chemical Engineering Journal, 2025, 521

[30] Co-encapsulated nanoparticles of Erlotinib and Quercetin for targeting lung cancer through nuclear EGFR and PI3K/AKT inhibition [J].

Ganthala, Parimala Devi ;

Alavala, Sateesh ;

Chella, Naveen ;

Andugulapati, Sai Balaji ;

Bathini, Nagendra Babu ;

Sistla, Ramakrishna .

COLLOIDS AND SURFACES B-BIOINTERFACES, 2022, 211

← 1 2 3 4 5 →